US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist

1.850
0.0000.00%

Close Sep 27 16:00 ET

1.850
0.0000.00%

Post 16:00 ET

226.95MMarket Cap-2176P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

64.66%-21.86M

-12.59%-32.66M

-242.12%-168.88M

37.61%-31.96M

-184.40%-46.08M

-38.10%-61.83M

-264.61%-29.01M

64.74%-49.36M

-20.82%-51.23M

251.25%54.6M

Net income from continuing operations

55.31%-24.27M

65.63%-19.31M

15.94%-171.67M

56.50%-19.54M

30.35%-41.66M

-4.00%-54.31M

-18.84%-56.16M

-20.08%-204.21M

8.29%-44.92M

-31.54%-59.81M

Depreciation and amortization

24.38%403K

32.60%423K

63.65%1.52M

58.51%447K

100.47%427K

42.73%324K

55.61%319K

8.42%927K

33.65%282K

0.47%213K

Other non cash items

0.95%850K

-0.73%815K

-2.06%3.47M

-1.18%2.93M

-683.94%-1.13M

350.27%842K

323.20%821K

389.63%3.54M

391.06%2.97M

359.52%193K

Change In working capital

85.39%-1.98M

-186.25%-18.13M

-114.40%-18.76M

-41.66%-19.55M

-106.13%-6.68M

-859.44%-13.56M

-37.10%21.02M

1,192.24%130.32M

-1,619.93%-13.8M

2,498.88%108.92M

-Change in receivables

---1.57M

--0

200.00%30M

--0

--30M

---30M

--0

-Change in prepaid assets

90.08%-259K

-6.45%580K

-8.52%3.53M

169.09%3.78M

-14.31%1.75M

-396.48%-2.61M

234.20%620K

241.29%3.86M

2.48%1.4M

221.00%2.04M

-Change in payables and accrued expense

438.87%1.92M

-82.32%-10.21M

-285.79%-27.02M

-927.21%-12.74M

-164.99%-8.11M

-110.88%-566K

-19.56%-5.6M

11.40%14.54M

372.57%1.54M

196.51%12.48M

-Change in other current assets

----

--0

3.57%-2.05M

223.50%2.05M

----

--0

-1,281.67%-2.13M

-71.88%634K

-Change in other current liabilities

-16.85%-846K

9.61%-630K

-75.49%-3.14M

-1,467.14%-957K

-15.56%-765K

-16.77%-724K

-20.38%-697K

-37.56%-1.79M

206.06%70K

-14.93%-662K

-Change in other working capital

92.51%-723K

-138.46%-7.87M

-115.41%-22.14M

-149.52%-7.58M

-101.70%-1.6M

-125.35%-9.65M

-108.63%-3.3M

334,306.98%143.71M

139,300.00%15.31M

858,527.27%94.43M

Cash from discontinued investing activities

Operating cash flow

64.66%-21.86M

-12.59%-32.66M

-242.12%-168.88M

37.61%-31.96M

-184.40%-46.08M

-38.10%-61.83M

-264.61%-29.01M

64.74%-49.36M

-20.82%-51.23M

251.25%54.6M

Investing cash flow

Cash flow from continuing investing activities

201.38%5.51M

-5,296.78%-72.55M

178.50%119.88M

144.35%20.15M

729.30%103.78M

93.99%-5.44M

524.32%1.4M

-23,467.28%-152.72M

-29,207.10%-45.43M

-35,750.00%-16.49M

Net PPE purchase and sale

--0

85.51%-132K

1.32%-2.17M

50.83%-386K

-10.80%-472K

39.27%-399K

-176.90%-911K

-239.04%-2.2M

-406.45%-785K

-826.09%-426K

Net investment purchase and sale

209.40%5.51M

-3,238.93%-72.42M

181.09%122.05M

146.00%20.53M

748.93%104.25M

94.39%-5.04M

--2.31M

---150.52M

---44.64M

---16.07M

Cash from discontinued investing activities

Investing cash flow

201.38%5.51M

-5,296.78%-72.55M

178.50%119.88M

144.35%20.15M

729.30%103.78M

93.99%-5.44M

524.32%1.4M

-23,467.28%-152.72M

-29,207.10%-45.43M

-35,750.00%-16.49M

Financing cash flow

Cash flow from continuing financing activities

-99.79%153K

-72.95%5.83M

-38.13%94.68M

-99.78%92K

-101.37%-146K

80.57%73.18M

-64.32%21.55M

140.42%153.02M

43.98%41.46M

2,197.62%10.64M

Net issuance payments of debt

28.79%-47K

0.00%-65K

-51.47%-412K

-232.31%-216K

0.00%-65K

0.00%-66K

14.47%-65K

-101.48%-272K

-100.35%-65K

0.00%-65K

Net common stock issuance

-100.09%-66K

-73.10%5.85M

-38.01%93.54M

--0

-100.76%-81K

79.78%71.89M

-64.01%21.73M

250.21%150.89M

307.54%39.94M

20,870.59%10.59M

Proceeds from stock option exercised by employees

-80.38%266K

41.18%48K

-35.39%1.55M

-90.03%158K

--0

123.76%1.36M

-64.58%34K

-3.27%2.4M

207.57%1.58M

-81.00%110K

Net other financing activities

----

--0

---150K

----

Cash from discontinued financing activities

Financing cash flow

-99.79%153K

-72.95%5.83M

-38.13%94.68M

-99.78%92K

-101.37%-146K

80.57%73.18M

-64.32%21.55M

140.42%153.02M

43.98%41.46M

2,197.62%10.64M

Net cash flow

Beginning cash position

-38.64%75.66M

35.31%175.04M

-27.50%129.36M

1.19%186.76M

-4.86%129.21M

-46.51%123.3M

-27.50%129.36M

-30.14%178.43M

-3.97%184.56M

-40.40%135.82M

Current changes in cash

-374.05%-16.19M

-1,539.85%-99.38M

193.10%45.68M

78.76%-11.72M

18.07%57.55M

106.24%5.91M

-111.63%-6.06M

36.27%-49.06M

-301.14%-55.2M

236.61%48.74M

End cash Position

-53.97%59.48M

-38.64%75.66M

35.31%175.04M

1.19%186.76M

-4.86%129.21M

-46.51%123.3M

-27.50%129.36M

-3.97%184.56M

Free cash flow

64.88%-21.86M

-9.60%-32.79M

-231.75%-171.05M

37.81%-32.35M

-185.94%-46.55M

-36.98%-62.23M

-261.13%-29.92M

63.34%-51.56M

-22.23%-52.01M

249.88%54.17M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	64.66%-21.86M	-12.59%-32.66M	-242.12%-168.88M	37.61%-31.96M	-184.40%-46.08M	-38.10%-61.83M	-264.61%-29.01M	64.74%-49.36M	-20.82%-51.23M	251.25%54.6M
Net income from continuing operations	55.31%-24.27M	65.63%-19.31M	15.94%-171.67M	56.50%-19.54M	30.35%-41.66M	-4.00%-54.31M	-18.84%-56.16M	-20.08%-204.21M	8.29%-44.92M	-31.54%-59.81M
Depreciation and amortization	24.38%403K	32.60%423K	63.65%1.52M	58.51%447K	100.47%427K	42.73%324K	55.61%319K	8.42%927K	33.65%282K	0.47%213K
Other non cash items	0.95%850K	-0.73%815K	-2.06%3.47M	-1.18%2.93M	-683.94%-1.13M	350.27%842K	323.20%821K	389.63%3.54M	391.06%2.97M	359.52%193K
Change In working capital	85.39%-1.98M	-186.25%-18.13M	-114.40%-18.76M	-41.66%-19.55M	-106.13%-6.68M	-859.44%-13.56M	-37.10%21.02M	1,192.24%130.32M	-1,619.93%-13.8M	2,498.88%108.92M
-Change in receivables	---1.57M	--0	200.00%30M	--0	--0	--0	--30M	---30M	---30M	--0
-Change in prepaid assets	90.08%-259K	-6.45%580K	-8.52%3.53M	169.09%3.78M	-14.31%1.75M	-396.48%-2.61M	234.20%620K	241.29%3.86M	2.48%1.4M	221.00%2.04M
-Change in payables and accrued expense	438.87%1.92M	-82.32%-10.21M	-285.79%-27.02M	-927.21%-12.74M	-164.99%-8.11M	-110.88%-566K	-19.56%-5.6M	11.40%14.54M	372.57%1.54M	196.51%12.48M
-Change in other current assets	----	----	--0	3.57%-2.05M	223.50%2.05M	----	----	--0	-1,281.67%-2.13M	-71.88%634K
-Change in other current liabilities	-16.85%-846K	9.61%-630K	-75.49%-3.14M	-1,467.14%-957K	-15.56%-765K	-16.77%-724K	-20.38%-697K	-37.56%-1.79M	206.06%70K	-14.93%-662K
-Change in other working capital	92.51%-723K	-138.46%-7.87M	-115.41%-22.14M	-149.52%-7.58M	-101.70%-1.6M	-125.35%-9.65M	-108.63%-3.3M	334,306.98%143.71M	139,300.00%15.31M	858,527.27%94.43M
Cash from discontinued investing activities
Operating cash flow	64.66%-21.86M	-12.59%-32.66M	-242.12%-168.88M	37.61%-31.96M	-184.40%-46.08M	-38.10%-61.83M	-264.61%-29.01M	64.74%-49.36M	-20.82%-51.23M	251.25%54.6M
Investing cash flow
Cash flow from continuing investing activities	201.38%5.51M	-5,296.78%-72.55M	178.50%119.88M	144.35%20.15M	729.30%103.78M	93.99%-5.44M	524.32%1.4M	-23,467.28%-152.72M	-29,207.10%-45.43M	-35,750.00%-16.49M
Net PPE purchase and sale	--0	85.51%-132K	1.32%-2.17M	50.83%-386K	-10.80%-472K	39.27%-399K	-176.90%-911K	-239.04%-2.2M	-406.45%-785K	-826.09%-426K
Net investment purchase and sale	209.40%5.51M	-3,238.93%-72.42M	181.09%122.05M	146.00%20.53M	748.93%104.25M	94.39%-5.04M	--2.31M	---150.52M	---44.64M	---16.07M
Cash from discontinued investing activities
Investing cash flow	201.38%5.51M	-5,296.78%-72.55M	178.50%119.88M	144.35%20.15M	729.30%103.78M	93.99%-5.44M	524.32%1.4M	-23,467.28%-152.72M	-29,207.10%-45.43M	-35,750.00%-16.49M
Financing cash flow
Cash flow from continuing financing activities	-99.79%153K	-72.95%5.83M	-38.13%94.68M	-99.78%92K	-101.37%-146K	80.57%73.18M	-64.32%21.55M	140.42%153.02M	43.98%41.46M	2,197.62%10.64M
Net issuance payments of debt	28.79%-47K	0.00%-65K	-51.47%-412K	-232.31%-216K	0.00%-65K	0.00%-66K	14.47%-65K	-101.48%-272K	-100.35%-65K	0.00%-65K
Net common stock issuance	-100.09%-66K	-73.10%5.85M	-38.01%93.54M	--0	-100.76%-81K	79.78%71.89M	-64.01%21.73M	250.21%150.89M	307.54%39.94M	20,870.59%10.59M
Proceeds from stock option exercised by employees	-80.38%266K	41.18%48K	-35.39%1.55M	-90.03%158K	--0	123.76%1.36M	-64.58%34K	-3.27%2.4M	207.57%1.58M	-81.00%110K
Net other financing activities	----	----	----	----	--0	--0	---150K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-99.79%153K	-72.95%5.83M	-38.13%94.68M	-99.78%92K	-101.37%-146K	80.57%73.18M	-64.32%21.55M	140.42%153.02M	43.98%41.46M	2,197.62%10.64M
Net cash flow
Beginning cash position	-38.64%75.66M	35.31%175.04M	-27.50%129.36M	1.19%186.76M	-4.86%129.21M	-46.51%123.3M	-27.50%129.36M	-30.14%178.43M	-3.97%184.56M	-40.40%135.82M
Current changes in cash	-374.05%-16.19M	-1,539.85%-99.38M	193.10%45.68M	78.76%-11.72M	18.07%57.55M	106.24%5.91M	-111.63%-6.06M	36.27%-49.06M	-301.14%-55.2M	236.61%48.74M
End cash Position	-53.97%59.48M	-38.64%75.66M	35.31%175.04M	35.31%175.04M	1.19%186.76M	-4.86%129.21M	-46.51%123.3M	-27.50%129.36M	-27.50%129.36M	-3.97%184.56M
Free cash flow	64.88%-21.86M	-9.60%-32.79M	-231.75%-171.05M	37.81%-32.35M	-185.94%-46.55M	-36.98%-62.23M	-261.13%-29.92M	63.34%-51.56M	-22.23%-52.01M	249.88%54.17M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data